REFERENCES
- Testimony of Kathryn C. Zoon, Ph.D., Director, Center for Biologics Evaluation and Research, Food and Drug Administration presented on April 29, 1999, http://www.fda.gov/ola/anthraxvaccine.html (accessed December 3, 1999)
- US Army Medical Research Institute of Infectious Diseases. Medical Management of Biological Casualties. 2nd Ed., Fort Detrick, , MD 1996
- Keim M., Kauffmann A. F. Emergency Response to Bioterrorism. Ann. Emerg. Med. 1999; 2: 177–182
- Department of Defense. Anthrax Vaccine Immunization Program, http://www.anthrax.osd.mil (accessed December 3, 1999)
- Information Paper: The Anthrax Vaccine, http://www.abcs.com/spanky/vaccine.htm (accessed April 15, 1999)
- Farchaus J. W., Ribot W. J., Jendrek S., Little S. F. Fermentation, Purification, and Characterization of Protective Antigen from a Recombinant, Avirulent Strain of Bacillus anthracis. Appl. Environ. Microbiol. 1998; 3: 982–991
- Singh Y., Ivins B. E., Leppla S. H. Study of Immunization Against Anthrax with the Purified Recombinant Protective Antigen of Bacillus anthracis. Infect. Immun. 1998; 7: 3447–3448
- The Anthrax Vaccine, http://millennium.fortunecity.com/redwood/352/usmc5.htm (accessed April 15, 1999)
- Brown F. Vaccination Today and Tomorrow. Biosci. Rep. 1995; 6: 493–502
- Jones A. P. Asthma and Domestic Air Quality. Soc. Sci. Med. 1998; 6: 755–764
- Ziem G. Profile of Patients with Chemical Injury and Sensitivity. Environ. Health Perspect. 1997; 105: 417–436
- Imbus H. R. Clinical Evaluation of Patients with Complaints Related to Formaldehyde Exposure. J. Allergy Clin. Immunol. 1985; 6: 831–840
- Nass M. Anthrax Vaccine. Model of a Response to the Biologic Warfare Threat. Infect. Dis. Clin. North Am. 1999; 1: 187–208